Gabapentine Impurity 27 | CAS 103985-51-9 - Request Quote
Gabapentine Impurity 27
| SZ CAT No: | SZ-G001047 |
| CAS No | 103985-51-9 |
| Mol.F. | C10H18O2 |
| Mol.Wt. | 170.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Gabapentine Impurity 27 is chemically 2-Isopropylcyclohexane-1-carboxylic acid. Gabapentine Impurity 27 is supplied with detailed characterization data compliant with regulatory guideline. Gabapentine Impurity 27 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Gabapentin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 103985-51-9
Purchase 103985-51-9
Order 103985-51-9
Enquire 103985-51-9
price of 103985-51-9
103985-51-9 Supplier
103985-51-9 Manufacturer
103985-51-9 Exporter
buy high quality Gabapentine Impurity 27
Purchase Gabapentine Impurity 27
Gabapentine Impurity 27 suppliers
Gabapentine Impurity 27 manufacturers
Gabapentine Impurity 27 price
Order Gabapentine Impurity 27
Enquire Gabapentine Impurity 27
Gabapentine Impurity 27 cost
Gabapentine Impurity 27 Supplier
Gabapentine Impurity 27 Distributor
Gabapentine Impurity 27 for Method Validation
Gabapentin Reference Standard
Gabapentine Impurity 27 for ANDA Filing
Gabapentine Impurity 27 for Forced Degradation Studies
Gabapentine Impurity 27 Identification Standards
Gabapentine Impurity 27 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


